×
Hypothesis: Possible influence of antivector immunity and SARS-CoV-2 variants on effica...
https://doi.org/10.1111/bph.15620
British Journal of Pharmacology; Zamai L, Rocchi MBL

Aug 1st, 2021 - The present work provides arguments for the involvement of anti-vector immunity and of SARS-CoV-2 variants on the efficacy of ChAdOx1 nCoV-19 vaccine. First, it is suggested that anti-vector immunity takes place as homologous vaccination with ChAdOx1 nCoV-19 vaccine is applied and interferes with vaccine efficacy when the interval between prime and booster doses is less than 3 months. Second, l...

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
https://doi.org/10.1016/j.jaut.2021.102710
Journal of Autoimmunity; Vuille-Lessard É, Montani M et. al.

Aug 1st, 2021 - The development of autoimmune diseases has been reported after SARS-CoV-2 infection. Vaccination against SARS-CoV-2 could also trigger auto-immunity, as it has been described with other vaccines. An aberrant immune response induced by molecular mimicry and bystander activation, especially in predisposed individuals, is a potential mechanism. We report the case of a 76-year-old woman with Hashim...

SARS-CoV-2 specific T cell responses are lower in children and increase with age and ti...
https://doi.org/10.1038/s41467-021-24938-4 10.1128/JCM.02107-20 10.1126/science.abc4776 10.1016/j.chom.2020.11.007 10.1038/s41586-021-03471-w 10.1056/NEJMoa2035002 10.1038/s41586-021-03291-y 10.1016/j.cell.2020.04.026 10.1172/JCI137244 10.1038/s41586-021-03631-y 10.1016/j.cell.2020.09.038 10.1016/j.cell.2021.02.010 10.1038/s41591-020-1083-1 10.1016/j.cell.2020.05.015 10.1126/science.abd3871 10.1038/s41586-020-2550-z 10.1016/j.immuni.2020.11.016 10.1038/s41586-020-03041-6 10.1016/j.cell.2020.11.029 10.1038/s41591-020-0965-6 10.1016/j.cell.2020.08.017 10.1038/s41591-020-0819-2 10.3201/eid2612.203833 10.1038/s41467-020-19545-8 10.1038/s41591-020-0995-0 10.1016/S1473-3099(20)30599-5 10.1126/sciimmunol.aan5393 10.1172/JCI114970 10.3389/fimmu.2018.00498 10.3389/fimmu.2014.00294 10.1002/JLB.4HI0720-470R 10.1126/sciimmunol.abd6197 10.1016/j.vaccine.2016.11.059 10.1182/blood-2003-12-4341 10.1038/nm.3350 10.1073/pnas.1112520108 10.1038/s41467-019-13788-w 10.1038/ncomms7301 10.1084/jem.194.7.953 10.1038/s41467-021-22236-7 10.1126/science.abi5273 10.1038/s41590-020-00826-9 10.1038/s41467-020-20247-4 10.1016/j.cell.2020.12.015 10.1038/s41590-020-0782-6 10.1371/journal.pone.0077412 10.1038/s41598-018-37167-5 10.1128/JVI.01460-06 10.1038/s41586-021-03207-w
Nature Communications; Cohen CA, Li APY et. al.

Jul 31st, 2021 - SARS-CoV-2 infection of children leads to a mild illness and the immunological differences with adults are unclear. Here, we report SARS-CoV-2 specific T cell responses in infected adults and children and find that the acute and memory CD4+ T cell responses to structural SARS-CoV-2 proteins increase with age, whereas CD8+ T cell responses increase with time post-infection. Infected children hav...

Vaccination Alone Won't Counter Rise of Resistant Variants: Study
https://www.medscape.com/viewarticle/955777

Jul 30th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Relaxation of nonpharmaceutical interventions once vaccination of the population has reached a tipping point short of herd immunity can increase the probability of the emergence of a resistant strain that natural selection then favors, according to new findings of a modeling study published onli...

Traditional medicines prescribed for prevention of COVID-19: Use with caution.
https://doi.org/10.1111/nep.13947
Nephrology (Carlton, Vic.); Parthasarathy R, Mathew M et. al.

Jul 30th, 2021 - Acute interstitial nephritis can result due to exposure to any medication, toxins, infections or malignancy. In the midst of this Coronavirus (COVID-19) pandemic, there has been a race for finding remedies to prevent the spread of and control the complications due to Severe Acute Respiratory Syndrome Coronavirus 2. Certain Indian medicinal herb concoctions like kabasura kudineer and nilavembu k...

Lower seroprevalence for SARS-CoV-2-specific antibodies among kidney transplant recipie...
https://doi.org/10.1111/tid.13706
Transplant Infectious Disease : an Official Journal of Th... Cristelli MP, Viana LA et. al.

Jul 30th, 2021 - Kidney transplant recipients have higher COVID-19 associated mortality compared to the general population. However, as only symptomatic patients seek medical attention, the current level of exposure, the main sources of acquisition and the behavior of humoral immunity over time are poorly understood. This cross-sectional prospective single-center study recruited kidney transplant recipients of ...

COVID-19 vaccination in Chinese children: a cross-sectional study on the cognition, psy...
https://doi.org/10.1080/21645515.2021.1949950
Human Vaccines & Immunotherapeutics; Yang J, Zhang T et. al.

Jul 30th, 2021 - It is important to understand the cognition, willingness, and psychological anxiety state of Chinese guardians toward COVID-19 vaccination for their children to predict the future vaccination rate and to help the design of policies that aim to expand the population with immunity against COVID-19. This study collected data with a professional vaccination registration platform for children named ...

Vitamin D, infections and immunity.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318777
Reviews in Endocrine & Metabolic Disorders; Ismailova A, White JH

Jul 30th, 2021 - Vitamin D, best known for its role in skeletal health, has emerged as a key regulator of innate immune responses to microbial threat. In immune cells such as macrophages, expression of CYP27B1, the 25-hydroxyvitamin D 1α-hydroxylase, is induced by immune-specific inputs, leading to local production of hormonal 1,25-dihydroxyvitamin D (1,25D) at sites of infection, which in turn directly induces...

COVID-19, corticosteroids and public health: a reappraisal.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180552
Public Health; Fernandes M, Brábek J

Jul 30th, 2021 - To assess whether regulatory guidance on the use of dexamethasone in hospitalised COVID-19 patients is applicable to the larger population of COVID-19 cases. The surge in worldwide demand for dexamethasone suggests that the guidance, although correct, has not emphasised the danger of its wider use. Data from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial and the World Health Org...

COVID-19: Are Experimental Drugs Cure or Ill?
https://doi.org/10.2174/1574886316666210727150127
Current Drug Safety; Karahalil B, Elkama A

Jul 29th, 2021 - Coronavirus disease 2019 (COVID-19) is a new strain of coronavirus. It is characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has quickly influenced all over the world since it spreads easily. Common symptoms are fever, cough, difficulty in breathing and muscle aches. Despite the urgent need to find an effective antiviral treatment, already available agents are bei...

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine.
https://doi.org/10.1038/s41586-021-03841-4
Nature Oberhardt V, Luxenburger H et. al.

Jul 29th, 2021 - SARS-CoV-2 spike mRNA vaccines1-3 mediate protection from severe disease as early as 10 days post prime vaccination3, when neutralizing antibodies are hardly detectable4-6. Vaccine-induced CD8+ T cells may thus be the main mediators of protection at this early stage7,8. The details of their induction, comparison to natural infection, and association with other arms of vaccine-induced immunity r...

Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310664
The Journal of Infection; Gidari A, Sabbatini S et. al.

Jul 29th, 2021 - The emergence of new variants of concern (VOCs) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) around the world significantly complicated the exit from Coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to evaluate the serum neutralizing activity of three cohorts. BNT162b2-elicited serum (N=103), candidates as hyper-immune plasma donors (N=90) and patients ...

US COVID Cases Likely Undercounted by Up to 60%, New Model Shows
https://www.medscape.com/viewarticle/955594

Jul 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. As many as 60% of COVID-19 cases in the United States likely have gone undetected, according to new research published online in the Proceedings of the National Academy of Sciences. Adrian Raftery, PhD, professor of sociology and statistics, along with statistics doctoral student Nicholas Irons,...

The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moder...
https://doi.org/10.4049/jimmunol.2100446
Journal of Immunology (Baltimore, Md. : 1950); Shahbaz S, Xu L et. al.

Jul 28th, 2021 - Understanding the function of SARS-CoV-2 Ag-specific T cells is crucial for the monitoring of antiviral immunity and vaccine design. Currently, both impaired and robust T cell immunity is described in COVID-19 patients. In this study, we explored and compared the effector functions of SARS-CoV-2-reactive T cells expressing coinhibitory receptors and examine the immunogenicity of SARS-CoV-2 S, M...

Repurposing of the childhood vaccines: could we train the immune system against the SAR...
https://doi.org/10.1080/14760584.2021.1960161
Expert Review of Vaccines; Sharma D

Jul 28th, 2021 - The COVID-19 pandemic is a globalized health concern caused by a beta-coronavirus named Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Since, December 2019 when this outbreak flared in Wuhan, China, COVID-19 cases have been continuously rising all over the world. Due to the emergence of SARS-CoV-2 mutants, subsequent waves are flowing in a faster manner as compared to the primary...

COVID-19 control in the United States: the case for masking.
https://doi.org/10.37765/ajmc.2021.88670
The American Journal of Managed Care; Maki DG, Alter SM et. al.

Jul 28th, 2021 - As of May 2021, the United States remains the world leader with 33 million of 165 million cases worldwide (20%) and 590,000 of 3.4 million deaths worldwide (17%) from COVID-19. Achieving herd immunity by disease spread and vaccination may result in 2 million to 4 million total US deaths. The future perfect of the vaccine should not be the enemy of the present good, which is masking. Masking, es...

Adverse COVID-19 Outcomes in Immune Deficiencies; Inequality Exists Between Subclasses.
https://doi.org/10.1111/all.15025
Allergy Karakoc Aydiner E, Bilgic Eltan S et. al.

Jul 28th, 2021 - Genetic deficiencies of immune system, referred to as inborn errors of immunity (IEI), serve as a valuable model to study human immune responses. In a multicenter prospective cohort, we evaluated the outcome of SARS-CoV-2 infection among IEI subjects and analyzed genetic and immune characteristics that determine adverse COVID-19 outcomes. We studied 34 IEI patients (19M/15F, 12 (min:0.6-max:43)...

Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
https://doi.org/10.1073/pnas.2103272118
Proceedings of the National Academy of Sciences of the Un... Irons NJ, Raftery AE

Jul 28th, 2021 - There are multiple sources of data giving information about the number of SARS-CoV-2 infections in the population, but all have major drawbacks, including biases and delayed reporting. For example, the number of confirmed cases largely underestimates the number of infections, and deaths lag infections substantially, while test positivity rates tend to greatly overestimate prevalence. Representa...

Mucosal vaccines - fortifying the frontiers.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312369
Nature Reviews. Immunology; Lavelle EC, Ward RW

Jul 28th, 2021 - Mucosal vaccines offer the potential to trigger robust protective immune responses at the predominant sites of pathogen infection. In principle, the induction of adaptive immunity at mucosal sites, involving secretory antibody responses and tissue-resident T cells, has the capacity to prevent an infection from becoming established in the first place, rather than only curtailing infection and pr...

Maternal COVID-19 disease, vaccination safety in pregnancy, and evidence of protective ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305214
The Journal of Allergy and Clinical Immunology; Pham A, Aronoff DM et. al.

Jul 28th, 2021 - Maternal COVID-19 disease, vaccination safety in pregnancy, and evidence of protective immunity.|2021|Pham A,Aronoff DM,Thompson JL,|